Literature DB >> 17960799

Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's disease.

Barbara Leinweber1, J Carsten Möller, Andre Scherag, Ulrike Reuner, Peter Günther, Christoph J G Lang, Hartmut H J Schmidt, Christoph Schrader, Oliver Bandmann, Anna Czlonkowska, Wolfgang H Oertel, Harald Hefter.   

Abstract

Wilson's disease (WD) is an inherited autosomal-recessive disorder of copper metabolism characterized by a wide variety of neurological, hepatic, and psychiatric symptoms. The aim of the present study was the development and evaluation of a clinical rating scale, termed Unified Wilson's Disease Rating Scale (UWDRS), to assess the whole spectrum of clinical symptoms in WD. Altogether 107 patients (mean age 37.6 +/- 11.9 years; 46 male, 61 female) with treated WD participated in the study. Cronbach's alpha as a measure of the internal consistency for the entire scale was 0.92, whereas the intraclass correlation coefficient (ICC) was 0.98 (confidence interval (CI(95%)) 0.97-0.99), indicating an excellent interrater reliability as determined in 32 patients. Besides the total score was significantly correlated with the earning capacity of the patients as indicated by an estimated Spearman's rho approximately 0.54 (CI(95%) 0.40-0.69, P < 0.001). In summary, the UWDRS appears to be a promising tool to assess the disease severity in WD. Its usefulness in clinical research and drug trials should be further addressed. 2007 Movement Disorder Society

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 17960799     DOI: 10.1002/mds.21761

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  23 in total

Review 1.  Encephalopathy in Wilson disease: copper toxicity or liver failure?

Authors:  Peter Ferenci; Tomasz Litwin; Joanna Seniow; Anna Czlonkowska
Journal:  J Clin Exp Hepatol       Date:  2014-09-22

Review 2.  Clinical presentations of Wilson disease.

Authors:  Samuel Shribman; Thomas T Warner; James S Dooley
Journal:  Ann Transl Med       Date:  2019-04

Review 3.  Neurologic impairment in Wilson disease.

Authors:  Petr Dusek; Tomasz Litwin; Anna Członkowska
Journal:  Ann Transl Med       Date:  2019-04

Review 4.  Evolving perspectives in Wilson disease: diagnosis, treatment and monitoring.

Authors:  Karl Heinz Weiss; Wolfgang Stremmel
Journal:  Curr Gastroenterol Rep       Date:  2012-02

5.  Inhibitory rTMS applied on somatosensory cortex in Wilson's disease patients with hand dystonia.

Authors:  Pierre Lozeron; Aurélia Poujois; Elodie Meppiel; Sana Masmoudi; Thierry Peron Magnan; Eric Vicaut; Emmanuel Houdart; Jean-Pierre Guichard; Jean-Marc Trocello; France Woimant; Nathalie Kubis
Journal:  J Neural Transm (Vienna)       Date:  2017-07-08       Impact factor: 3.575

6.  Altered large-scale functional brain networks in neurological Wilson's disease.

Authors:  Rixing Jing; Yongsheng Han; Hewei Cheng; Yongzhu Han; Kai Wang; Daniel Weintraub; Yong Fan
Journal:  Brain Imaging Behav       Date:  2020-10       Impact factor: 3.978

Review 7.  Wilson's disease and other neurological copper disorders.

Authors:  Oliver Bandmann; Karl Heinz Weiss; Stephen G Kaler
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

8.  Higher Concentration of Plasma Glial Fibrillary Acidic Protein in Wilson Disease Patients with Neurological Manifestations.

Authors:  Jie Lin; Yexiang Zheng; Ying Liu; Yi Lin; Qiqi Wang; Xiao-Hong Lin; Wenli Zhu; Wei-Hong Lin; Ning Wang; Wan-Jin Chen; Ying Fu
Journal:  Mov Disord       Date:  2021-01-27       Impact factor: 10.338

9.  The impact of Wilson disease on myocardial tissue and function: a cardiovascular magnetic resonance study.

Authors:  Janek Salatzki; Isabelle Mohr; Jannick Heins; Mert H Cerci; Andreas Ochs; Oliver Paul; Johannes Riffel; Florian André; Kristóf Hirschberg; Matthias Müller-Hennessen; Evangelos Giannitsis; Matthias G Friedrich; Uta Merle; Karl Heinz Weiss; Hugo A Katus; Marco Ochs
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-24       Impact factor: 5.364

10.  Designing Clinical Trials in Wilson's Disease.

Authors:  Peter Ott; Aurélia Poujois; Thomas Damgaard Sandahl; Karl Heinz Weiss; Peter Ferenci; Michael L Schilsky; Aftab Ala; Frederick K Askari; Anna Czlonkowska; Ralf-Dieter Hilgers; Eve A Roberts
Journal:  Hepatology       Date:  2021-10-05       Impact factor: 17.298

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.